SKP2 and melanoma: In melanoma cells, the efficacy of MLN4924 has been correlated with the ability of preventing the degradation of p21WAF1, a known substrate of SKP2 [37], providing an indirect demonstration of a link between the levels of SKP2 and the efficacy of MLN4924.